Jeff Elkins

Jeff Elkins has over 30 years of experience across a range of leadership and operational roles in both large and start-up medical device companies, primarily focused on emerging endovascular and interventional technologies. Mr. Elkins was most recently President and CEO of Veniti, a venous stent company which was acquired by Boston Scientific.  Prior to that, Mr. Elkins held multiple roles including VP of Operations, COO, and CEO at Aptus EndoSystems, acquired by Medtronic; Founder, VP Operations/COO and CEO of FlowMedica, acquired by AngioDynamics; and VP Operations and CTO for World Medical Corp, acquired by Medtronic. Mr. Elkins has also held the role of Vice President and Business Unit Manager for the Endovascular Division of Medtronic. He also had various Operations and R&D/Product Development and management responsibilities at Cordis and Cordis Endovascular Systems Interventional Neuro (acquired by Johnson &Johnson), and Haemonetics Corporation.  Mr. Elkins received his BS in Mechanical Engineering from U Massachusetts, Amherst.